InvestorsHub Logo
Followers 151
Posts 86857
Boards Moderated 1
Alias Born 11/29/2003

Re: None

Wednesday, 07/01/2015 9:13:05 AM

Wednesday, July 01, 2015 9:13:05 AM

Post# of 376163
Gapping up


In reaction to strong earnings/guidance: AVAV +4.5%, STZ +2.6%, GIS +1.7%, SBLK +0.5%

M&A news: CB +31.9% (ACE (ACE) will acquire Chubb for ~$124.13/share in cash and stock), ACE +7.2%, GPT +3.3% (Gramercy Property Trust and Chambers Street Properties (CSG) to merge; combined company will have an enterprise value of $5.7 bln)

Other news: TLOG +45.3% (announced positive preliminary data from the ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes), BIOC +19.6% (announced the launch of its FGFR1 amplification testing utilizing a patient's blood sample), ESI +15.9% (disclosed submission of its audited consolidated financial statements to the U.S. Department of Education on June 26, 2015, ahead of the June 30 due date), PRAN +13.7% (cont strength), NBG +13.3% (optimism that Greece will accept latest terms), TBIO +7.8% (announces a private placement of 1.5 mln restricted common shares with Crede Capital Group for $1.42/share), PDEX +6.8% (still checking), MBI +6% (Reuters reporting that Puerto Rico's PREPA utility is close to a deal with creditors to avoid a default; MBI has exposure to Puerto Rican debt), GLNG +5.8% (reached an agreement with Perenco for the floating liquefied natural gas export project in Cameroon), FRO +5.3% (may be benefitting from Greece news), RDHL +5.2% (receives two notices of allowance from the USPTO for RHB-104), KITE +5% (Kite Pharma and The Leukemia & Lymphoma Society announce a partnership to enhance the development of Kite's lead product candidate, KTE-C19), TRV +3.8% (CB, ACE peer), TTM +3.6% (reports June 2015 total commercial and passenger vehicle sales), WYNN +2.9% (Macau data), FIT +2.9% (cont vol post IPO), LVS +2.9% (Macau data), KMDA +2.9% (granted patent by the Israeli Patent Office that covers claims regarding the unique combination of Kamada's inhaled alpha-1 proteinase inhibitor with a customized eFlow nebulizer system), AIRT +2.6% (awarded contract in excess of $32 mln for the supply of 2200 aircraft deicing vehicles to American Airlines), IHG +2.5% (still checking), JUNO +1.9% (cont momentum), FEYE +1.6% (cont momentum), MRH +1.5% (Montpelier Re and Endurance Specialty shareholders vote in favor of the proposed merger)

Analyst comments: NVGN +8.5% (initiated with a Buy at H.C. Wainwright; tgt $8.50 ), VIP +4.6% (upgraded to Buy from Neutral at BofA/Merrill), CS +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley ), Z +1.8% ( initiated with a Buy at Guggenheim), AINV +1.3% (initiated with a Buy at Jefferies ), FB +1.2% (raised to $100 from $92 at Cantor Fitzgerald)



Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ee3h5WdI

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.